Microphysiological systems (MPS), also known as organ-on-a-chip systems, and organoids are innovative technologies used in biomedical research to model human physiology and diseases in vitro. MPS are microscale platforms that mimic the structure and function of human organs or tissues, typically incorporating cells, scaffolds, and microfluidic channels to create microenvironments that replicate physiological conditions. Organoids, on the other hand, are three-dimensional clusters of cells grown from stem cells or tissue samples that self-organize and differentiate into structures resembling specific organs. These systems offer unique advantages for studying human biology and disease mechanisms, enabling researchers to recapitulate complex tissue architecture and cellular interactions in a controlled laboratory setting. MPS and organoids hold great promise for drug discovery, toxicity testing, disease modeling, and personalized medicine applications, facilitating the development of more effective therapies and treatments.

The global Microphysiological System and Organoids market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Microphysiological System and Organoids Industry Forecast” looks at past sales and reviews total world Microphysiological System and Organoids sales in 2022, providing a comprehensive analysis by region and market sector of projected Microphysiological System and Organoids sales for 2023 through 2029.

This Insight Report provides a comprehensive analysis of the global Microphysiological System and Organoids landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue
• Market share
• Latest development
• M&A activity

This report also analyses the strategies of leading global companies with a focus on Microphysiological System and Organoids portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microphysiological System and Organoids market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microphysiological System and Organoids and breaks down the forecast by:

• Type
• Application
• Geography
• Market size

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microphysiological System and Organoids.

United States market for Microphysiological System and Organoids is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Microphysiological System and Organoids is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Microphysiological System and Organoids is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Microphysiological System and Organoids players cover:

• Emulate
• Mimetas
• InSphero
• TissUse
• CN Bio

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Microphysiological System and Organoids market by product type, application, key players, and key regions and countries.

Segmentation by Type:

• Human Organ and Tissue Models
• Disease Models
• Non-Human Species Models

Segmentation by Application:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

This report also splits the market by region:

1. Americas
   • United States
   • Canada
   • Mexico
   • Brazil
2. APAC
   • China
   • Japan
   • Korea
   • Southeast Asia
   • India
   • Australia
3. Europe
   • Germany
   • France
   • UK
   • Italy
   • Russia
4. Middle East & Africa
   • Egypt
   • South Africa
   • Israel
   • Turkey
   • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Emulate
• Mimetas
• InSphero
• TissUse
• CN Bio
• Valo Health (TARA Biosystems)
• Hesperos
• TNO
• AxoSim
• Newcells Biotech
• Nortis
• Netri
• Draper Laboratory
• Beijing Daxiang Biotech
• Altis Biosystems
• Cherry Biotech
• Bi/ond
• Obatala Sciences
• Ananda Devices
• ImmuONE
• React4life
• AlveoliX
• BiomimX
• Aracari Bio
• StemPharm
• SynVivo